Session

IBD (Posters)

CHANGE IN URGENCY AMONG CROHN’S DISEASE PATIENTS: ANALYSES FROM THE SPARC IBD
CHANGE IN URGENCY AMONG CROHN’S DISEASE PATIENTS: ANALYSES FROM THE SPARC IBD

IBD (Posters)  et al.

AN AUDIT OF PROACTIVE THERAPEUTIC DRUG MONITORING OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON BIOLOGICS
AN AUDIT OF PROACTIVE THERAPEUTIC DRUG MONITORING OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON BIOLOGICS

IBD (Posters)  et al.

RELATIONSHIP BETWEEN HISTO-ENDOSCOPIC MUCOSAL HEALING AND BASELINE CHARACTERISTICS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS RECEIVING FILGOTINIB IN THE PHASE 2B/3 SELECTION STUDY
RELATIONSHIP BETWEEN HISTO-ENDOSCOPIC MUCOSAL HEALING AND BASELINE CHARACTERISTICS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS RECEIVING FILGOTINIB IN THE PHASE 2B/3 SELECTION STUDY

IBD (Posters)  et al.

REAL-WORLD TREATMENT PATTERNS AND HEALTHCARE COSTS AMONG US COMMERCIALLY INSURED ADULTS INITIATING BIOLOGICS FOR ULCERATIVE COLITIS
REAL-WORLD TREATMENT PATTERNS AND HEALTHCARE COSTS AMONG US COMMERCIALLY INSURED ADULTS INITIATING BIOLOGICS FOR ULCERATIVE COLITIS

IBD (Posters)  et al.

A REAL-WORLD EVALUATION OF TOFACITINIB FOR ULCERATIVE COLITIS IN UK AND IRELAND
A REAL-WORLD EVALUATION OF TOFACITINIB FOR ULCERATIVE COLITIS IN UK AND IRELAND

IBD (Posters)  et al.

THE USE OF PANENTERIC CROHN’S CAPSULES TO ASSESS TREATMENT OUTCOME OF VEDOLIZUMAB IN IBD PATIENTS: A 1 YEAR PROOF OF CONCEPT STUDY
THE USE OF PANENTERIC CROHN’S CAPSULES TO ASSESS TREATMENT OUTCOME OF VEDOLIZUMAB IN IBD PATIENTS: A 1 YEAR PROOF OF CONCEPT STUDY

IBD (Posters)  et al.

AGE MAY NOT IMPACT BIOLOGIC TREATMENT FAILURE AT 12 MONTHS FOR INFLAMMATORY BOWEL DISEASE: A REAL LIFE RETROSPECTIVE SINGLE CENTRE COHORT STUDY
AGE MAY NOT IMPACT BIOLOGIC TREATMENT FAILURE AT 12 MONTHS FOR INFLAMMATORY BOWEL DISEASE: A REAL LIFE RETROSPECTIVE SINGLE CENTRE COHORT STUDY

IBD (Posters)  et al.

TASTY & HEALTHY IS A DIETARY APPROACH FOR INDUCING AND MAINTAINING REMISSION IN CROHN'S DISEASE: A PROSPECTIVE CASE SERIES
TASTY & HEALTHY IS A DIETARY APPROACH FOR INDUCING AND MAINTAINING REMISSION IN CROHN'S DISEASE: A PROSPECTIVE CASE SERIES

IBD (Posters)  et al.

THE OUTCOME OF COLONOSCOPIC SURVEILLANCE AND SURGERY IN A COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS WHO DEVELOPED COLO-RECTAL CANCER OVER A 12 YEAR REVIEW PERIOD AT A DISTRICT GENERAL HOSPITAL
THE OUTCOME OF COLONOSCOPIC SURVEILLANCE AND SURGERY IN A COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS WHO DEVELOPED COLO-RECTAL CANCER OVER A 12 YEAR REVIEW PERIOD AT A DISTRICT GENERAL HOSPITAL

IBD (Posters)  et al.

VACCINATION AGAINST SARS-COV-2 IN IBD: ACCEPTANCE AND CONCERNS IN A COHORT FROM SOUTHERN ITALY
VACCINATION AGAINST SARS-COV-2 IN IBD: ACCEPTANCE AND CONCERNS IN A COHORT FROM SOUTHERN ITALY

IBD (Posters)  et al.

EFFECTIVENESS AND SAFETY OF ON-DEMAND FERRIC CARBOXYMALTOSE INFUSION STRATEGY FOR IRON DEFICIENCY ANEMIA IN INFLAMMATORY BOWEL DISEASE PATIENTS
EFFECTIVENESS AND SAFETY OF ON-DEMAND FERRIC CARBOXYMALTOSE INFUSION STRATEGY FOR IRON DEFICIENCY ANEMIA IN INFLAMMATORY BOWEL DISEASE PATIENTS

IBD (Posters)  et al.

HEAVY PSEUDOPOLYP BURDEN IN INFLAMMATORY BOWEL DISEASE PREDICTS MORE SEVERE DISEASE: A MULTICENTRE COHORT STUDY
HEAVY PSEUDOPOLYP BURDEN IN INFLAMMATORY BOWEL DISEASE PREDICTS MORE SEVERE DISEASE: A MULTICENTRE COHORT STUDY

IBD (Posters)  et al.

INCIDENCE AND EVOLUTION OF SARS-COV2 INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN SOUTHERN SPAIN (ANDALUSIA)
INCIDENCE AND EVOLUTION OF SARS-COV2 INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN SOUTHERN SPAIN (ANDALUSIA)

IBD (Posters)  et al.

RISK OF TYPE 2 DIABETES AFTER SMALL AND LARGE BOWEL RESECTIONS: A NATIONWIDE COHORT STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
RISK OF TYPE 2 DIABETES AFTER SMALL AND LARGE BOWEL RESECTIONS: A NATIONWIDE COHORT STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

MICRORNA PROFILING ON THE LEVELS OF COLON TISSUE AND EPITHELIAL CELL-POPULATIONS IN PATIENTS WITH ACTIVE AND INACTIVE ULCERATIVE COLITIS
MICRORNA PROFILING ON THE LEVELS OF COLON TISSUE AND EPITHELIAL CELL-POPULATIONS IN PATIENTS WITH ACTIVE AND INACTIVE ULCERATIVE COLITIS

IBD (Posters)  et al.

FREQUENCY AND EFFECTIVENESS OF EMPIRICAL ANTI-TNF DOSE INTENSIFICATION IN INFLAMMATORY BOWEL DISEASE: SYSTEMATIC REVIEW WITH META-ANALYSIS
FREQUENCY AND EFFECTIVENESS OF EMPIRICAL ANTI-TNF DOSE INTENSIFICATION IN INFLAMMATORY BOWEL DISEASE: SYSTEMATIC REVIEW WITH META-ANALYSIS

IBD (Posters)  et al.

PROTEOMIC AND LIPIDOMIC ANALYSIS REVEAL ALTERATIONS OF COMPLEMENT ACTIVATION AND LIPID METABOLISM IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE
PROTEOMIC AND LIPIDOMIC ANALYSIS REVEAL ALTERATIONS OF COMPLEMENT ACTIVATION AND LIPID METABOLISM IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

DOES BIOTIN DEFICIENCY PLAY A ROLE IN IBD PATHOGENESIS? PRELIMINARY RESULTS OF A CROSS-SECTIONAL STUDY
DOES BIOTIN DEFICIENCY PLAY A ROLE IN IBD PATHOGENESIS? PRELIMINARY RESULTS OF A CROSS-SECTIONAL STUDY

IBD (Posters)  et al.

IS VITAMIN D DEFICIENCY RELATED TO FAT MALABSORPTION OR INFLAMMATION IN INFLAMMATORY BOWEL DISEASE? PRELIMINARY RESULTS FROM THE FAT-D STUDY
IS VITAMIN D DEFICIENCY RELATED TO FAT MALABSORPTION OR INFLAMMATION IN INFLAMMATORY BOWEL DISEASE? PRELIMINARY RESULTS FROM THE FAT-D STUDY

IBD (Posters)  et al.

SENSITIVITY AND SPECIFICITY OF DIFFERENT PARAMETERS FOR THE DIAGNOSIS AND DIFFERENTIATION OF IRON DEFICIENCY IN INFLAMMATORY BOWEL DISEASE
SENSITIVITY AND SPECIFICITY OF DIFFERENT PARAMETERS FOR THE DIAGNOSIS AND DIFFERENTIATION OF IRON DEFICIENCY IN INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

Item 361 - 380 / 568
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18
19
20 21 22 23 24 25 26 27 28 29